Kenvue, Inc. ( (KVUE) ) has issued an update.
On March 5, 2025, Kenvue Inc. announced a cooperation agreement with Starboard Value, resulting in the appointment of three new directors to its Board: Sarah Hofstetter, Erica Mann, and Jeffrey C. Smith. This strategic move temporarily expands the Board from 11 to 14 members and aligns with Starboard’s commitment to support Kenvue’s director nominees at the 2025 Annual Meeting. The agreement aims to enhance Kenvue’s growth and shareholder value, with Starboard withdrawing its previous director nominations and agreeing to a standstill period.
More about Kenvue, Inc.
Kenvue Inc. is the world’s largest pure-play consumer health company by revenue, known for its iconic brands such as Aveeno, BAND-AID, Johnson’s, Listerine, Neutrogena, and Tylenol. The company focuses on providing science-backed health products recommended by healthcare professionals globally.
YTD Price Performance: 10.79%
Average Trading Volume: 13,610,564
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $44.76B
For detailed information about KVUE stock, go to TipRanks’ Stock Analysis page.